T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 30,198 | 9,789 | N/A |
| TOTAL | $30,393 | $9,849 | $N/A |
| Non-Current Assets | |||
| PPE Net | 1,118 | 1,195 | N/A |
| Other Non-Current Assets | 374 | 387 | 0 |
| TOTAL | $1,492 | $1,582 | $N/A |
| Total Assets | $31,885 | $11,431 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 943 | 571 | 0 |
| Accrued Expenses | 1,319 | 733 | N/A |
| TOTAL | $4,046 | $2,129 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 3,299 | 5,058 | N/A |
| Deferred Revenues | 25 | 5 | N/A |
| Other Non-Current Liabilities | 1,225 | 695 | 0 |
| TOTAL | $4,569 | $5,823 | $N/A |
| Total Liabilities | $8,615 | $7,952 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 1 | 1 | N/A |
| Retained earnings | -89,544 | -62,659 | N/A |
| Other shareholders' equity | 112,813 | 66,137 | 0 |
| TOTAL | $23,270 | $3,479 | $N/A |
| Total Liabilities And Equity | $31,885 | $11,431 | $0 |